ADYNOVATE

Product Overview

About ADYNOVATE

ADYNOVATE is a recombinant antihemophilic factor, pegylated, used for the treatment and control of bleeding in patients with hemophilia A. It is a medication that replaces the clotting factor missing in patients with this condition, helping to prevent or control bleeding episodes.

Key Benefits & Uses

• Treatment and control of bleeding in patients with hemophilia A
• Prevention of bleeding episodes in patients with hemophilia A
• Control of bleeding in patients undergoing surgery or invasive procedures

Active Ingredient & Action

ADYNOVATE contains ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED, which is a recombinant form of factor VIII. This medication works by replacing the missing or defective factor VIII in patients with hemophilia A, helping to restore normal blood clotting and prevent bleeding.

Important Notes

ADYNOVATE should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosing schedule and to report any adverse reactions or concerns to your doctor. Additionally, patients with hemophilia A should be aware of the signs and symptoms of bleeding and seek medical attention if they experience any unusual bleeding or bruising.